Cargando…
Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBD), encompassing both Crohn Disease (CD) and ulcerative colitis (UC) are globally prevalent diseases, impacting children of all ages. The hallmark of IBD is a perturbed immune system that leads to continuous inflammation in the gut and challenges optimal treatment. Nuc...
Autores principales: | Zaidi, Deenaz, Wine, Eytan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218406/ https://www.ncbi.nlm.nih.gov/pubmed/30425977 http://dx.doi.org/10.3389/fped.2018.00317 |
Ejemplares similares
-
Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020) -
Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease
por: Zaidi, Deenaz, et al.
Publicado: (2018) -
Investigation of Leoligin Derivatives as NF-κΒ Inhibitory Agents
por: Linder, Thomas, et al.
Publicado: (2021) -
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
por: Suryavanshi, Sachin V., et al.
Publicado: (2017) -
LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells
por: Liu, HaiDan, et al.
Publicado: (2009)